Published in Circulation on March 29, 2004
Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull (2011) 4.27
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol (2006) 4.02
Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. J Natl Cancer Inst (2008) 2.14
Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem (2009) 2.03
Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging (2009) 1.66
C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med (2007) 1.64
Population differences in associations between C-reactive protein concentration and adiposity: comparison of young adults in the Philippines and the United States. Am J Clin Nutr (2009) 1.37
Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res (2008) 1.33
Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis (2009) 1.26
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol (2007) 1.25
Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. Rheumatology (Oxford) (2009) 1.24
The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 1.21
Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol (2007) 1.21
Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort. PLoS One (2012) 1.20
Adiposity and pathogen exposure predict C-reactive protein in Filipino women. J Nutr (2008) 1.19
Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis. PLoS One (2009) 1.09
Discordant risk: overweight and cardiometabolic risk in Chinese adults. Obesity (Silver Spring) (2013) 1.09
Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord (2009) 1.08
Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep (2014) 1.07
Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals. AIDS Res Hum Retroviruses (2010) 1.04
Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav Immun (2011) 1.02
High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazone. J Diabetes Sci Technol (2010) 1.00
Inflammation in renal transplantation. Clin J Am Soc Nephrol (2009) 0.99
Distribution of 10-year and lifetime predicted risk for cardiovascular disease prior to surgery in the longitudinal assessment of bariatric surgery-2 study. Am J Cardiol (2012) 0.96
Individual and neighborhood socioeconomic status and inflammation in Mexican American women: what is the role of obesity? Psychosom Med (2012) 0.95
CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res (2011) 0.95
Air Pollution from Road Traffic and Systemic Inflammation in Adults: A Cross-Sectional Analysis in the European ESCAPE Project. Environ Health Perspect (2015) 0.93
C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology (2010) 0.92
The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis (2010) 0.92
CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol (2012) 0.90
The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences. Vasc Health Risk Manag (2009) 0.89
Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival. Cardiovasc Pathol (2012) 0.89
C-reactive protein induces M-CSF release and macrophage proliferation. J Leukoc Biol (2008) 0.88
Sleep Health: Reciprocal Regulation of Sleep and Innate Immunity. Neuropsychopharmacology (2016) 0.88
Infliximab, a TNF-α inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. J Hum Hypertens (2013) 0.87
Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun (2014) 0.86
Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis. Ther Clin Risk Manag (2010) 0.86
Association between mobility mode and C-reactive protein levels in men with chronic spinal cord injury. Arch Phys Med Rehabil (2008) 0.84
The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. J Cardiovasc Nurs (2010) 0.84
Fatigue in systemic lupus erythematosus. Int J Clin Rheumtol (2012) 0.84
Systemic inflammation and early atheroma formation: are they related? Maedica (Buchar) (2010) 0.83
Is very high C-reactive protein in young adults associated with indicators of chronic disease risk? Psychoneuroendocrinology (2013) 0.82
C-Reactive protein predicts acute myocardial infarction during high-risk noncardiac and vascular surgery. Clinics (Sao Paulo) (2011) 0.82
Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women. Arthritis Care Res (Hoboken) (2014) 0.82
Visualising noncalcified coronary plaques by CT. Int J Cardiovasc Imaging (2005) 0.81
Poor self-reported health and its association with biomarkers among Canadian Inuit. Int J Circumpolar Health (2012) 0.81
Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats. J Diabetes Complications (2012) 0.81
Long-term effects of birth weight and breastfeeding duration on inflammation in early adulthood. Proc Biol Sci (2014) 0.81
Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins. J Natl Med Assoc (2005) 0.81
Neighborhoods and systemic inflammation: high CRP among legal and unauthorized Brazilian migrants. Health Place (2012) 0.81
Associations of C-Reactive Protein to Indices of Vascular Health and the Influence of Serum 25(OH)D Status in Healthy Adults. J Nutr Metab (2012) 0.80
Children with both asthma and depression are at risk for heightened inflammation. J Pediatr (2013) 0.80
Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int J Cardiol (2010) 0.80
High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study. J Neurol (2009) 0.79
Increased preoperative C-reactive protein levels are associated with inhospital death after coronary artery bypass surgery. Inflammation (2012) 0.79
Interaction of Vitamin D and Smoking on Inflammatory Markers in the Urban Elderly. J Prev Med Public Health (2015) 0.79
Increased visceral adipose tissue as a potential risk factor in patients with embolic stroke of undetermined source (ESUS). PLoS One (2015) 0.79
Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect. Mediators Inflamm (2014) 0.78
Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study. J Diabetes Sci Technol (2009) 0.78
Impact of OSA on biological markers in morbid obesity and metabolic syndrome. J Clin Sleep Med (2014) 0.78
Protective Effects of BDNF against C-Reactive Protein-Induced Inflammation in Women. Mediators Inflamm (2015) 0.78
Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging. Cardiovasc Diagn Ther (2015) 0.77
Association of serum hs-CRP and lipids with obesity in school children in a 12-month follow-up study in Japan. Environ Health Prev Med (2014) 0.77
Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism. Clinics (Sao Paulo) (2015) 0.76
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis. Clin Rheumatol (2016) 0.75
High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients. J Headache Pain (2015) 0.75
Predictive role of high sensitive C-reactive protein in early onset mortality after ischemic stroke. Iran J Neurol (2012) 0.75
Prognostic Importance of C-Reactive Protein in High Cardiovascular Risk Patients With Type 2 Diabetes Mellitus: The Rio de Janeiro Type 2 Diabetes Cohort Study. J Am Heart Assoc (2016) 0.75
Cardiovascular biomarkers and their utility in the older adult. Curr Cardiovasc Risk Rep (2012) 0.75
Thyroid Function and High-Sensitivity C-Reactive Protein in Cross-Sectional Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Effect of Adiposity and Insulin Resistance. Eur Thyroid J (2016) 0.75
Parental support buffers the association of depressive symptoms with cortisol and C-reactive protein during adolescence. Brain Behav Immun (2016) 0.75
A new surgical technique versus an old marker: can expansion sphincter pharyngoplasty reduce C-reactive protein levels in patients with obstructive sleep apnea? Eur Arch Otorhinolaryngol (2016) 0.75
Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation (2007) 3.20
A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med (2006) 3.19
Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. Circulation (2005) 1.89
Built to last. Undertake market research before embarking on facility expansion or renovation. Mark Health Serv (2007) 1.37
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37
Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34
Blood pressure differences by ethnic group among United States children and adolescents. Hypertension (2009) 1.27
The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2010) 1.08
Random-effects meta-analysis of inconsistent effects. Ann Intern Med (2014) 0.96
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol (2016) 0.78
No effect of beta-carotene supplementation on risk of nonmelanoma skin cancer among men with low baseline plasma beta-carotene. Cancer Epidemiol Biomarkers Prev (2004) 0.76